Browse the full insider trade history of U S Physical Therapy INC /nv, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, U S Physical Therapy INC /nv has recorded 64 insider filings. Market capitalisation: €955.9m. The latest transaction was filed on 18 May 2022 — Attribution. Among the most active insiders: Chapman Harry S. All data is free.
0 of 0 declarations
U.S. Physical Therapy, Inc. (NYSE, NYSE Texas: USPH) is a U.S.-based healthcare services company focused on outpatient rehabilitation and industrial injury prevention. Headquartered in Houston, Texas, United States, the company was founded in 1990 and has grown through a partnership-oriented model that combines owned clinics with locally managed operating relationships. Today, USPH operates a broad national network of outpatient physical therapy clinics across numerous U.S. states, giving it meaningful geographic diversification and exposure to a large, fragmented market. USPH’s business is organized into two reportable segments. The core outpatient physical therapy segment provides preventive and post-operative care, treatment for orthopedic and sports-related injuries, rehabilitation for injured workers, and therapy for certain neurologic conditions. Its industrial injury prevention segment serves employer clients on site, offering injury-prevention programs, rehabilitation support, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. This dual-platform structure is strategically important: it broadens revenue streams, deepens relationships with employers and healthcare networks, and gives the company exposure to both patient-driven and B2B healthcare demand. From a competitive standpoint, USPH holds a solid position in a highly fragmented outpatient therapy industry where many local practices remain independent. Scale matters in this sector, and USPH has long used acquisitions as a key growth lever. Recent company announcements show that this strategy remains active: in 2025 and 2026, USPH completed and announced several acquisitions of multi-clinic physical therapy practices and an industrial injury prevention business, while also expanding through strategic alliances with major hospital systems. That pattern suggests a continued emphasis on disciplined consolidation, expanding clinical reach, and strengthening referral relationships. For investors, USPH presents a relatively resilient healthcare services profile supported by recurring rehabilitation demand, employer-focused occupational health services, and a proven acquisition playbook. The company’s recent disclosures also indicate ongoing investor communications through earnings releases and conference presentations, underscoring management’s focus on execution and capital allocation. In short, U.S. Physical Therapy is a niche but sizeable U.S. healthcare operator listed on the NYSE, with a hybrid model that combines outpatient care delivery and industrial injury prevention services, and with continued room for growth through selective acquisitions and network expansion.